Views and analysis

Building a better future for people with rare diseases in all four UK nations

https://pharmaphorum.com/views-analysis-patients/building-a-better-future-for-people-with-rare-diseases-in-all-four-uk-nations/

Rare disease insights from the patient community

https://pharmaphorum.com/views-and-analysis/rare-disease-insights-from-the-patient-community/

2021 market access prospects for Spain

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-spain/

2021 market access prospects for Germany

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-germany/

Common but not normal: It’s time to talk about maternal mental health

https://pharmaphorum.com/views-analysis-patients/common-but-not-normal-its-time-to-talk-about-maternal-mental-health/

West Africa prepares for Ebola vaccination program

https://pharmaphorum.com/views-and-analysis/west-africa-prepares-for-ebola-vaccination-program/

Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4

https://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-pipeline-continues-to-provide-drama-as-investors-look-beyond-covid-in-q4/

No cooling off for pharma digital transformation in 2021

https://pharmaphorum.com/views-analysis-digital/no-cooling-off-for-pharma-digital-transformation-in-2021/

Reality Check | Is Your Current Customer Engagement Solution the Best Choice for All Markets?

https://pharmaphorum.com/views-analysis-sales-marketing/is-your-customer-engagement-solution-the-best-choice-for-all-markets/

< 1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search